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Reduced up-regulation of the nitric oxide
pathway and impaired endothelial and
smooth muscle functions in the female
type 2 diabetic goto-kakizaki rat heart
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Abstract
Background: Type 2 diabetes is associated with greater relative risk of cardiovascular diseases in women than in
men, which is not well understood. Consequently, we have investigated if male and female displayed differences in
cardiac function, energy metabolism, and endothelial function which could contribute to increased cardiovascular
complications in type 2 diabetic female.
Methods: Male and female Control and type 2 diabetic Goto-Kakizaki (GK) isolated rat hearts were perfused during
28 min with a physiological buffer before freeze-clamping for biochemical assays. High energy phosphate compounds
and intracellular pH were followed using 31P magnetic resonance spectroscopy with simultaneous measurement of
contractile function. Nitric oxide (NO) pathway and endothelium-dependent and independent vasodilatations were
measured as indexes of endothelial function. Results were analyzed via two-way ANOVA, p < 0.05 was considered as
statistically significant.
Results: Myocardial function was impaired in male and female diabetic versus Control groups (p < 0.05) without
modification of energy metabolism. Coronary flow was decreased in both diabetic versus Control groups but to a
higher extent in female GK versus male GK rat hearts (p < 0.05). NO production was up-regulated in diabetic groups
but to a less extent in female GK rat hearts (p < 0.05). Endothelium-dependent and independent vasodilatations were
impaired in female GK rat compared with male GK (p < 0.05) and female Control (p < 0.05) rat hearts.
Conclusions: We reported here an endothelial damage characterized by a reduced up-regulation of the NO pathway
and impaired endothelial and smooth muscle functions, and coronary flow rates in the female GK rat hearts while
energy metabolism was normal. Whether these results are related to the higher risk of cardiovascular complications
among type 2 diabetic female needs to be further elicited in the future.
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Background
Cardiovascular diseases (CVDs) are the major causes of
morbidity and mortality in patients with diabetes
mellitus. CVDs are long-term complications of type 2 dia-
betes mellitus, with a two-fold increased risk of heart fail-
ure and greater mortality after myocardial infarction [1].
Diabetic women have a greater relative risk for CVDs than
diabetic men, and newly diagnosed diabetic women
showed higher relative risk for cardiovascular death than
diabetic men in the large DECODE study [2]. Women
with type 2 diabetes may undergo even more adverse
changes in coagulation, inflammation and vascular func-
tion than men [3, 4]. Stronger associations have been
reported between insulin resistance/metabolic syndrome
and inflammation and endothelial dysfunction in women
than in men [5]. Interestingly, it is proposed that women
have to undergo greater metabolic deterioration than men
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to develop type 2 diabetes and as such many insulin resist-
ance risk factors must change to a greater extent [6].
However, few studies have explored the sex differences in
the emerging risk factor profile in individuals with or
without type 2 diabetes. Consequently, we have investi-
gated if male and female without ischemic insult already
displayed differences in cardiac function, energy metabol-
ism, and endothelial function which could contribute to
increased cardiovascular complications in type 2 diabetic
female. This study was performed in male and female type
2 Goto-Kakizaki (GK) rats.
Six independent genetic loci are responsible for the
defects in glucose and insulin metabolism in the Goto-
Kakizaki (GK) rat, a highly inbred strain derived from
outbred, glucose-intolerant Wistar rats that spontan-
eously develop type 2 diabetes within the first few weeks
of age [7]. The GK is one of the best-characterized ani-
mal models of spontaneous type 2 diabetes mellitus [8].
In this model, cardiac insulin resistance was associated
with impaired insulin signaling pathway [9]. We have
previously shown greater hypertrophy, lower insulin-
stimulated glucose uptake rates and increased ischemic
injury in the female compared with the male GK rat
hearts [10]. In addition, modification of the NO pathway
was involved in increased susceptibility of the type 2 dia-
betic GK rat heart to ischemic injury [11]. Significantly,
this model allows one to study the effect of diabetes on
the heart without other complications such as obesity.
Here, the effect of gender on type 2 diabetic heart was
assessed in male and female Control Wistar and GK iso-
lated rat hearts perfused with a physiological buffer as
described previously [11]. High-energy phosphates and
intracellular pH were measured during the experimental
time course by 31P magnetic resonance spectroscopy
with simultaneous measurement of contractile function.
Energy compounds and oxidative stress in cardiac tis-
sues were evaluated by High Performance Liquid
Chromatography (HPLC). Myocardial tissue content of
creatine kinase and lactate dehydrogenase were also used
as markers of cellular damage. Total nitrate concen-
tration as well as expression of endothelial nitric
oxide synthase, AKT and Phospho-Akt were deter-
mined as markers of the NO pathway. Endothelium-
dependent and independent vasodilatations were also
measured in separate experiments in order to assess,
respectively, endothelial and smooth muscle functions.
A preliminary form of this study has been published
as an abstract [12].
Methods
Animals
Age-matched Control Wistar (male, n = 19; female, n = 24)
and Goto-Kakizaki rats (GK/Par subline [8]) (male, n = 22;
female, n = 23) (7–8 mo, weight 265–512 g) were used in
the experiments. Animals were fed ad libitum with a com-
mercial pelleted chow (diet 113, SAFE, Augy, France).
Heart perfusion and experimental protocol
Rats were anaesthetized by intraperitoneal injection of
35 mg/kg pentobarbital sodium. After removal of the
heart, blood samples were taken from the chest cavity
and immediately centrifuged, and the supernatant was
kept on ice for determination of plasma glucose and free
fatty acids (FFAs). Hearts were cannulated and perfused
in the Langendorff mode at constant pressure as
described previously [11]. The end-diastolic pressure
was set to 10 mmHg for all groups at the beginning of
perfusion. Left ventricular developed pressure and heart
rate were monitored as previously reported [13]. The
rate pressure product (RPP) (product of left ventricular
developed pressure and heart rate) was used as an index
of cardiac function [11]. Coronary flow was measured by
time collection of the coronary venous effluent.
Experimental protocol for 31P magnetic resonance
spectroscopy and biochemical analyses
Control (male n = 10, female n = 14) and GK (male n =
13, female n = 12) hearts were perfused during 4 min
with non-recirculating phosphate-free Krebs-Henseleit
bicarbonate buffer which had the following composition
(mM): NaCl (118), KCl (4.7), CaCl2 (1.75), MgSO4 (1.2),
ethylenediaminetetraacetate tetrasodium (0.5), NaHCO3
(25) and glucose (11). After stabilization, hearts were
perfused for 28 min with a physiological recirculating
Krebs-Henseleit buffer containing 0.4 mM palmitate, 3%
albumin, 11 mM glucose, 3U/L insulin, 0.8 mM lactate
and 0.2 mM pyruvate. The perfusion solutions were
gassed with a mixture of 95% oxygen and 5% carbon
dioxide to give a pH of 7.4 and the temperature was
maintained at 37 °C.
31P magnetic resonance spectroscopy on isolated perfused
rat heart
Perfused rat hearts were placed in a 20-mm magnetic
resonance sample tube and inserted into a 31P probe
that was seated in the bore of a superconducting wide-
bore (89-mm) 4.7 Tesla magnet (Oxford Instruments,
Oxford, UK) interfaced with a Bruker-Nicolet WP-200
spectrometer (Bruker, Karlsruhe, Germany). 31P spectra
were obtained by the accumulation of 328 free induction
decay signals acquired during 4 min (flip angle, 45°; time
resolution = 0.7 s; spectral width, 4500 Hz; 2048 data
points). Prior to Fourier transformation, the free induc-
tion decay was multiplied by an exponential function
which generated a 20-Hz line broadening. The appropri-
ate conditions for acquiring 31P magnetic resonance
spectra, the quantification of phosphorus metabolites
and the determination of intracellular pH have been
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detailed previously [11]. Quantification of the signal in-
tegrals was carried out using an external reference con-
taining an aqueous solution of 0.6 M phenylphosphonic
acid. A series of eight 31P NMR spectra were recorded
during the perfusion protocol.
Collection of data
Heart function and 31P magnetic resonance spectra were
simultaneously monitored during the perfusion protocol.
Blood samples were collected immediately after excising
the heart. For biochemical analyses, hearts were rapidly
freeze-clamped with a Wollenberger clamp precooled in
liquid nitrogen at the end of the experimental protocol
and kept at −80 °C before analysis.
Biochemical analyses in plasma
Plasma glucose and free fatty acids (FFAs) were deter-
mined as described previously [11].
Biochemical analyses in freeze-clamped hearts
Creatine, phosphocreatine, adenine nucleotides and
malondialdehyde (MDA)
Determination of creatine, phosphocreatine, adenine nu-
cleotides and MDA was performed as described previ-
ously [11]. MDA was used to evaluate lipid peroxidation
as a measure of oxidative stress [14].
Lactate dehydrogenase (LDH) and creatine kinase (CK) activities
and water content
LDH, CK and water content were measured as previ-
ously described [15].
NO pathway
Total nitrate concentration as well as total protein
expression of Akt, Phospho-Akt and endothelial NOS
(eNOS) were measured to assess the NO pathway.
Total nitrate concentration (NOx) NOx was deter-
mined according to the method described by Cross et
al. [16].
Protein expression of Akt, Phospho-Akt and eNOS
A portion of cardiac tissue was homogenized as
described by Ye et al. [17]. Protein samples (50 μg for
Akt, Phospho-Akt and 90 μg for eNOS) were run with
4–20% Tris–HCl ready gel (Thermo Scientific) or 6%
SDS-PAGE, respectively and transferred to pure nitro-
cellulose membrane. The membranes were incubated
overnight at 4 °C with primary antibodies against eNOS
(1/1000, Becton Dickinson (DB) Transduction Laboratories,
USA), Akt (1/1000, Cell Signaling Technology, Inc.),
Phospho-Akt (Ser473)(1/1000, Cell Signaling Technology,
Inc.) and β-actin (1/5000, Sigma) and secondarily with
HRP-conjugated anti-mouse or anti-rabbit antibodies
(Santa Cruz Biotechnology, Inc.). The immunoblots
were developed using ECLTM Western Blotting Detec-
tion Reagent (AmershamTM). The protein signals were
quantified using the MicroChemi 4.2 system (DNR
Bio-Imaging Systems Ltd., Israel). The intensity of
each protein signal was normalized to the corre-
sponding β-actin stain signal. Data are expressed as
ratios between the protein and the corresponding
β-actin signal density.
Endothelium dependent and independent vasodilatations
In separate experiments, endothelium-dependent and
independent vasodilatations were measured using 5-
hydroxytryptamine (5-HT, 10−7 M) and papaverine (5*10
−6 M) to assess endothelial and smooth muscle functions
respectively, as previously described [15] in Control
(male n = 9; female, n = 10) and GK (male, n = 9; female,
n = 11) isolated perfused rat hearts with Krebs-Henseleit
buffer. The 5-HT and papaverine hydrochloride were
dissolved in the buffer to give the desired concentration
and were obtained from Sigma Chemical Co. (St. Louis;
Missouri). The coronary flow was recorded during the
perfusion with the Krebs-Henseleit buffer and during
the infusion of 5-HT or papaverine. The increase in cor-
onary flow during drug infusion was calculated and
expressed as a percentage of the basal value.
Expression of results and statistical analyses
Data are expressed as means ± SEM. Function and 31P
magnetic resonance spectroscopy data are presented as
absolute values. Significant differences between groups
were determined using two-way ANOVA with repeated
measures over time for the time-dependent variables
(function and 31P magnetic resonance spectroscopy data)
followed by Bonferroni post-hoc test with Graphpad
Prism software (Graphpad prism 5.0, La Jolla, CA). For
biochemical data, the effects of time and group were an-
alyzed with two-way ANOVA followed by Bonferroni
post-hoc test. Unpaired Student’s t-test was used for
other parameters. A p value of less than or equal to 0.05
was considered to indicate significant difference.
Results
Physiological parameters of male and female Control and
GK rats
Plasma glucose was 67% and 69% higher in male and
female GK rats versus their respective Controls (Table 1,
p < 0.05). Plasma FFAs were similar in the four
groups (Table 1). Heart to body weight ratio was 23%
higher in male GK compared with male Control (Table 1,
p < 0.0001) due to a significantly lower body weight of
male GK compared with male Control (p < 0.05) and simi-
lar heart wet weights in both groups. In female GK, heart
to body weight ratio was 25% higher compared with
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female Control with a similar body weight in both groups
but a significantly higher heart weight in female GK versus
female Control (p < 0.0001).
Gender effect on myocardial function
Myocardial function as represented by the rate pressure
product (RPP), was significantly decreased in male and
female diabetic animals compared with the respective
Controls (p < 0.0001, Fig. 1a) due to a lower heart rate in
male and female GK rat hearts (p < 0.0001, Fig. 1b) vs
Controls. End diastolic pressure (EDP, mmHg) was not
different between groups (Control, male 10 ± 2, female
7 ± 2; GK male 8 ± 1, female 9 ± 2).
Coronary flow (CF) in Control and diabetic rat hearts
was shown in Fig. 2. CF was decreased in male and
female GK rat hearts compared with their respective
Controls (p = 0.0420 and p < 0.0001 respectively). Inter-
estingly, CF was significantly lower in female GK
Table 1 Physiological parameters in Control (male n = 10, female n = 14) and GK (male n = 13, female n = 12) rats
Control GK
Male Female Male Female
Plasma glucose mM 10.7 ± 0.3 10.0 ± 0.3 17.9 ± 0.6* 16.9 ± 0.4*
Plasma FFAs mM 0.27 ± 0.03 0.27 ± 0.05 0.28 ± 0.04 0.26 ± 0.04
Body weight g 512 ± 13 265 ± 7† 411 ± 4* 270 ± 5‡
Heart weight g 1.52 ± 0.03 0.88 ± 0.04† 1.51 ± 0.02 1.12 ± 0.03*‡
Ratio Heart/Body weight *1000 2.98 ± 0.05 3.34 ± 0.14† 3.66 ± 0.02* 4.17 ± 0.08*‡
*versus respective Controls, p < 0.0001. †versus Male Control, p < 0.05. ‡versus Male GK, p < 0.0001
















































Fig. 1 Rate pressure product (RPP, mmHg/min) (a) and Heart Rate (mmHg) (b) in Control (male n = 10, female n = 14) and GK (male n = 13, female n = 12)
rat hearts. Results are means ± SEM. * versus respective Controls, p < 0.0001
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compared with male GK rat hearts (p = 0.0137). No
difference was shown between male and female Control
rat hearts.
Gender effect on energy metabolism and intracellular
pH (pHi)
Kinetics of PCr (A), ATP (B) and intracellular pH (C) as
measured by 31P magnetic resonance spectroscopy are
shown in Fig. 3. No significant differences were found in
PCr and ATP contents in male and female diabetic and
Control rat hearts. pHi was the same in all groups with-
out any significant differences (Fig. 3c). Kinetics of phos-
phomonoesters (PME) and inorganic phosphate (Pi)
were shown in an (Additional file 1: Figure S3d and S3e,
respectively). PME and Pi were similar in all groups.
Gender effect on creatine, adenine nucleotide compounds
and oxidative stress
The total pool of creatine (creatine and phosphocrea-
tine) was similar in all groups (Table 2). No significant
difference was found in total adenine nucleotides and
adenylate energy charge between male and female con-
trol and diabetic rat hearts (Table 2). MDA content
(expressed in μmol/g protein), as an index of oxidative
stress, was not different in male and female GK rat
hearts (0.06 ± 0.01 and 0.05 ± 0.00 respectively) com-
pared with male and female Control rat hearts (0.06 ±
0.00 and 0.06 ± 0.00).
Gender effect on cellular damage and water content
LDH and CK activities (expressed in U/mg protein) were
similar in male (2.39 ± 0.10 and 5.96 ± 0.30) and female
(2.32 ± 0.11 and 5.62 ± 0.28) Controls, and male (2.40 ±
0.17 and 6.02 ± 0.35) and female (2.40 ± 0.23 and 5.89 ±
0.27) GK rat hearts. Water content, expressed as a
percentage, was not significantly different in male and
female Control (83.65 ± 0.75 and 83.10 ± 1.80) and GK
(83.62 ± 1.79 and 84.18 ± 0.91) rat hearts.
Gender effect on NO pathway
Total nitrate concentration (NOx)
Tissue NOx content in male and female Control and GK
rats was shown in Table 3. We found an increased NOx
in both diabetic groups compared with their respective
Controls, indicating up-regulation of the NO pathway,
but to a less extent in female GK rat hearts with a lower
NOx content in female compared with male GK rat
hearts (p = 0.0004).
Protein expression of Akt, Phospho-Akt and eNOS
Protein expressions of Akt, Phospho-Akt (A) and eNOS
(B) were given as ratios relative to actin protein content
and were shown in Fig. 4. We found similar protein
expressions of Akt and Phospho-Akt in the four groups
(Fig. 4a). Interestingly, eNOS expression (Fig. 4b) was
significantly increased in both male and female GK rat
hearts compared with their respective Controls without
any effect of gender (p < 0.05).
Gender effect on endothelial and smooth muscle functions
Endothelium-dependent and independent vasodilatations
were shown in Table 4. Endothelium-dependent and in-
dependent vasodilatations were not different in male
Control and GK rat hearts. By contrast, endothelium-
dependent and independent vasodilatations were signifi-
cantly impaired in female GK compared with male GK
(p < 0.05) and female Control (p < 0.05) rat hearts.
Discussion
The aim of the study was to investigate if male and female
without ischemic injury displayed differences in cardiac
function, energy metabolism, and endothelial function



































Fig. 2 Coronary flow (CF), expressed in ml/min/g heart weight, in Control (male n = 10, female n = 14) and GK (male n = 13, female n = 12) rat hearts.
Results are means ± SEM. * p = 0.0420 and † p < 0.0001, versus respective Controls; ‡ p = 0.0137, versus male GK rat hearts
Desrois et al. Nutrition & Metabolism  (2017) 14:6 Page 5 of 11
complications in type 2 diabetic female. Myocardial
function was impaired similarly in both male and
female diabetic GK rats. Cardiac energy metabolism
was normal in both diabetic groups compared with
their respective Controls. Conversely, coronary flow
was decreased in both diabetic groups but to a higher
level in female GK rat hearts. Total nitrate concentra-
tion was up-regulated in both diabetic groups but to
a less extent in female GK rat hearts. eNOS/actine
was similarly increased in both male and female GK
groups without modification of Akt pathway in all
groups. Endothelium-dependent and independent va-
sodilatations were impaired only in female GK rat
hearts. Together, these results could be related to
















































Fig. 3 Kinetics of phosphocreatine (PCr) (a), adenosine triphosphate (ATP) (b) and intracellular pH (pHi) (c) in Control (male n = 10, female n = 14)
and GK (male n = 13, female n = 12) rat hearts, measured by 31P magnetic resonance spectroscopy. Results are expressed in mM except pHi, and
are means ± SEM
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It is known than non-diabetic men are at more risk of
developing cardiovascular disease than non-diabetic
women. Interestingly, here the non-diabetic male and
female rats do not show any difference in coronary flow
or endothelial function which could be explained by the
lack of stress conditions such as ischaemic insult. How-
ever the relative risk of cardiovascular disease incidence
and mortality associated with type 2 diabetes compared
with non-diabetes is stronger in women than in men
[18, 19]. There are well characterized differences in trad-
itional risk factors among diabetic men and women
although these do not fully explain the gender differ-
ences observed. The reasons why diabetes in women in-
creases the relative risk of CHD more than in men
compared with their non-diabetic counterpart is not
clear, but a possible explanation may be that diabetes
has a greater adverse effect on CVD risk factors in
women than in men. Previous studies have shown differ-
ences in lipid abnormalities to be more pronounced
between diabetic and non-diabetic women than between
diabetic and nondiabetic men [20] but this dyslipidemia
appears insufficient to explain the differences in clinical
risk [21]. Wannamethee et al. [6] have reported that the
greater adverse influence of diabetes per se on abdom-
inal adiposity and insulin resistance, and down-stream
blood pressure, lipids (low HDL-cholesterol), endothelial
dysfunction (t-PA), and systemic inflammation (WBC) in
women compared with men may contribute to their
greater relative risk of coronary heart disease. Interest-
ingly, we have also previously reported higher insulin
resistance in the female than in the male GK rat hearts
[10]. Another possible explanation may be due to a need
for women to undergo much larger metabolic pertur-
bances to transit from non-diabetes to diabetes, ie in
general women may have to “deteriorate” more to get
diabetes, they need to put on more weight, and deterior-
ate their insulin sensitivity and related risk factors to a
greater extent than men [6]. On the other hand, the rea-
son for the greater relative risk of CVD associated with
diabetes in women compared with men may be also due
to the difference in the treatment of cardiovascular heart
disease risk factors between men and women or gender
response to therapy [22, 23].
Endothelial dysfunction is an early sign of diabetic vas-
cular disease and reduced endothelium-dependent vaso-
relaxation (EDV) to vasodilators is generally used as a
reproducible parameter to investigate the endothelial
function under various pathological conditions. Here,
the endothelial function was evaluated by a panel of
markers, including the NO pathway (NOx production
and AKT, Phospho-AKT and eNOS expression) com-
bined to endothelial and smooth muscle vasodilatations
and to the measurement of the coronary flow. NO pro-
duction was increased in both GK rat groups but was
less pronounced in female GK rat hearts. Total eNOS
protein expression was similarly increased in both
diabetic groups as reported before [11, 24] without any
effect of gender. AKT protein expression and phosphor-
ylation were similar in diabetic groups indicating that
AKT did not play a major role in gender effect on the
NO regulation. It has been hypothesized that upregula-
tion of eNOS in diabetes was a consequence of the
enhanced oxidative stress induced by hyperglycemia
[24–26] and inactivation of NO by the production of re-
active oxygen intermediates. MDA production, an index
of oxidative stress, was similar in both male and female
Control and GK rat hearts suggesting a normal oxidative
stress, by contrast to our previous study showing in-
creased MDA content in older male GK rat hearts [11].
Consequently, it would be interesting to evaluate both
reactive oxygen species production and the anti-oxidant
defence in male and female GK rat hearts in order to ac-
curately rule out a role of oxidative stress on NO modu-
lation in male and female type 2 diabetic GK rat hearts.
Finally, measuring the state of eNOS phosphorylation,
which is critical for NO synthesis, should be performed
to further investigate the NO pathway. Lower NO up-
regulation in female GK hearts is difficult to explain.
Decreased NO availability in female GK rat hearts may
be linked to a decrease in NOS activity due to increased
NOS uncoupling [24] and/or impaired intracellular
BH4/BH2 [27].
Decreased coronary flow and lower NOx content in
the female diabetic rat hearts were associated with
Table 2 Total pool of creatine, total adenine nucleotides and
adenylate energy charge in Control (male n = 10, female n = 14)
and GK (male n = 13, female n = 12) rat hearts
Control GK




94.3 ± 2.8 90.7 ± 4.6 90.9 ± 3.4 94.5 ± 1.6
TAN
μmol/g protein
40.9 ± 1.1 37.5 ± 1.3 38.2 ± 1.6 39.9 ± 1.3
AEC 0.83 ± 0.008 0.84 ± 0.007 0.84 ± 0.004 0.85 ± 0.008
TAN total adenine nucleotides (ATP + ADP+AMP), AEC adenylate energy
charge ((ATP + 0.5ADP)/(ATP +ADP+AMP) * 10)
Table 3 Total nitrate concentration (NOx) in Control (male n = 10,
female n = 14) and GK (male n = 13, female n = 12) rat hearts
Control GK
Male Female Male Female
NOx
nmol/mg protein
0.18 ± 0.02 0.19 ± 0.01 0.39 ± 0.03* 0.24 ± 0.01†‡
*p < 0.0001 versus Male Control rat hearts †p = 0.0113 versus Female Control
rat hearts
‡p = 0.0004 versus Male GK rat hearts
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impaired endothelium-dependent and independent vaso-
dilatations in the female GK rat hearts. By contrast, up-
regulation of the NO pathway in the male GK rat hearts
was probably involved in normal endothelial and smooth
muscle functions but, nevertheless, this was insufficient
for maintaining a normal coronary flow. Interestingly,
we have reported higher decrease in basal coronary flow
with higher increase in NOx production in male Control
and GK older animals (9–14 months) [11]. Impaired
endothelium-dependent vasorelaxation (EDV) has been
observed in both type 1 and type 2 diabetes [28],
wherever some studies have shown enhanced EDV in
diabetes [29]. Interestingly, Kobayashi et al. [30] reported
enhanced acetylcholine-induced relaxation and impaired
norepinephrine-induced contraction, due to NO over-
production via eNOS and increased α2D-adrenoceptor
expression in early-stage GK rats. Impaired acetylcholine-
induced relaxation in later-stage GK rats is due to reduc-
tions in both NO production and NO responsiveness.
Conflicting data were also obtained when responses to
vasoconstricting agents were studied [30, 31]. The reason
for these discrepancies is not clear. However, the duration
of the disease, among other factors, may play an important
role in the extent of the alteration of vascular reactivity to
vasodilating or vasoconstricting agents in diabetes [32].
Zhang et al. [33] demonstrated that Ach-induced relaxa-
tions were significantly impaired in mesenteric arteries
from both male and female diabetic rats at one and eight
weeks. Interestingly, the extent of impairment was signifi-
cantly greater in diabetic females than in diabetic males at
eight weeks suggesting a shift away from a putative
endothelium-derived hyperpolarizing factor (EDHF)
towards a greater reliance on NO. Several other re-
ports [34, 35] suggest that hyperglycemia and diabetes
affect male and female vascular beds differently. Clin-
ically, these differences reveal a stronger association



































































































Fig. 4 Protein expression of Akt, Phospho-Akt (a) and eNOS (b) in Control (male n = 10, female n = 14) and GK (male n = 13, female n = 12) rat hearts.
Protein expression were measured by western blot assay and results are expressed as a ratio relatively to actin protein content and are means ± SEM.
* versus respective Controls, p < 0.05
Table 4 Endothelium-dependent and independent vasodilatations
in Control (male n = 9, female n = 10) and GK (male n = 9, female
n = 11) rat hearts
Control GK
Male Female Male Female
5-HT % 32.6 ± 3.0 33.9 ± 3.3 30.5 ± 2.1 19.9 ± 2.6*†
Papaverine % 28.0 ± 3.7 29.4 ± 3.2 32.3 ± 4.4 19.2 ± 2.5*†
*p < 0.05 versus Male GK rat hearts. †p < 0.05 versus Female Control rat hearts
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[36, 37]. Interestingly, Goel et al. [34, 35] reported a
predisposition of female rabbit aorta compared with
male rabbit aorta toward impairment of endothelium-
dependent vasodilation under hyperglycemic condi-
tions, possibly via activation of PKCβ and superoxide
production. Gender differences in sex hormones may
be also one explanation for the differences in NO
production/release in GK rats. Vascular strips from
female rats were found to release more NO in
response to acetylcholine than vascular strips from
male rats [38]. These data suggest that estrogen may
directly stimulate NO production/release in women.
Conversely, the predominant male sex hormone tes-
tosterone (or other androgens) may cause decreased
NO production/release, as suggested by Herman [39].
Interestingly Al-Mulla et al. [40] reported reduced es-
trogen and increased testosterone levels in the female
GK rats and the possible roles of these hormones in
inflammatory processes involved in wound healing
impairment in type 2 diabetes. The independent con-
tributions of estrogens and androgens to the control
of endothelial function in normal and pathophysio-
logical states, especially in type 2 diabetes, remain to
be fully elucidated.
Myocardial function was significantly decreased in
female GK rats and to the same extent than in the male
GK rats. As suggested before [11], impaired cardiac
function was probably related to a significantly lower
heart rate in both GK rat hearts compared with their
Controls, possibly caused by hyperglycemia which alters
excitation-contraction coupling by lengthening the
period of mechanical relaxation [41]. On the other hand,
we have previously shown a 38% decreased protein level
of IRS1, one of the major insulin-signaling component,
in male GK rat hearts [9], which could be also involved
in impaired cardiac function in diabetic rats as reported
by Qi et al. [42]. Interestingly, Soliman et al. [43] re-
ported that the RhoA/ROCK pathway contributes to
contractile dysfunction in diabetic heart at least in part
by sustaining PKCβ2 activation, iNOS activation and
ROS production via a positive feedback loop that
requires an intact cytoskeleton. Mitochondrial dysfunc-
tion could be also involved in impaired cardiac function
in both GK rat heart groups as reported recently in
high-fat diet mice [44]. On the other hand, peroxisome
proliferator-activated receptors (PPARs) may also play a
role in functional and metabolic abnormalities of the
type 2 diabetic GK rat heart [45]. However, here cardiac
energy metabolism was normal in female GK rat hearts
and similar to the male GK rat heart suggesting normal
mitochondrial respiration in GK rat hearts. We have also
previously reported that increased susceptibility of older
male type 2 diabetic GK rat heart to ischemic injury was
not associated with impaired energy metabolism [11].
By contrast, reduced myocardial phosphocreatine/ATP
ratio, indicating impaired high energy phosphate-
metabolism and energy deficit [46, 47] has been reported
in human diabetic cardiomyopathy. However Diamant et
al. [48] found a decreased PCr/ATP in type 2 diabetic pa-
tients but did not confirm this finding in a subsequent
study with a group of well-controlled uncomplicated type
2 diabetic patients [49], probably due to differences in
patient characteristics.
Limitations
The experiments were conducted here on isolated perfused
hearts. In this model, we do not have the interactions with
the other organs and with the whole body physiology and
metabolism, which has both advantages and limitations.
The advantage of this model is to be able to study the in-
trinsic properties of the heart alone without the interactions
with the other organs and whole physiology.
On the other hand, studying the heart in vivo using
magnetic resonance imaging or echocardiography has an
additional value by taking in account the whole physi-
ology. In accordance with the results of the present
study, using multiparametric magnetic resonance im-
aging, we have previously shown that adult female GK
rats had defective myocardial blood flow associated with
altered left ventricular function in vivo [50], which is
consistent with the ex vivo results reported here.
Conclusion
Here, we studied hemodynamic function, energy metab-
olism, cellular integrity and endothelial function in male
and female Control and GK rat without ischemic insult
in order to check if gender differences already exist at
basal state which could explain increased cardiovascular
complications in type 2 diabetic female. We reported an
endothelial damage characterized by reduced up-
regulation of the NO pathway combined with impaired
endothelial and smooth muscle functions and coronary
flow rates in female diabetic rat hearts while energy me-
tabolism was normal. Whether these results and in-
volved molecular mechanisms are related to the higher
risk of cardiovascular complications among type 2 dia-
betic female waits to be further elicited in the future.
Additional file
Additional file 1: Figure S3. Kinetics of phosphomonoesters (PME) (D)
and inorganic phosphate (Pi) (E) in Control (male n = 10, female n = 14)
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resonance spectroscopy. Results are expressed in mM and are means ± SEM.
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